Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Osstem Vascular, formerly known as Osstem Cardio, is a South Korean medical device company specializing in cardiovascular and neurovascular intervention solutions. As a subsidiary of Osstem Implant, the company is recognized for developing the first Korean-made drug-eluting coronary stent and PTCA balloon catheter. Its commercial portfolio includes the CENTUM everolimus-eluting stent and the BeMotion series of balloon catheters, alongside neurovascular products like the Optima Coil System and Silk Vista flow diverters through a strategic partnership with the Balt Group. Osstem Vascular is focused on expanding its presence in the global vascular care market by providing high-quality, innovative devices for both cardiac and cerebrovascular treatments.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Osstem Cardio.